Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Biliary Tract Cancer”

1,007 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,007 results

Not applicableStudy completedNCT02841800
What this trial is testing

Intra-luminal Radiofrequency Ablation for Inoperable Malignant Biliary Stenosis

Who this might be right for
Liver CancerBile Duct CancerPancreatic Cancer
National Taiwan University Hospital 5
Not applicableStudy completedNCT00579865
What this trial is testing

Quality Of Life in Patients With Malignant Biliary Obstruction

Who this might be right for
Gallbladder CancerLiver CancerBile Duct Cancer
Memorial Sloan Kettering Cancer Center 124
Not applicableLooking for participantsNCT06101277
What this trial is testing

Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)

Who this might be right for
Esophageal CancerSmall Bowel CancerGastroesophageal-junction Cancer+8 more
University of California, Davis 300
Early research (Phase 1)Study completedNCT00626158
What this trial is testing

Gemcitabine and Capecitabine to Treat Patients With Advanced Pancreatic and Biliary Cancers

Who this might be right for
Pancreatic CancerBiliary Cancer
University of California, San Francisco 45
Testing effectiveness (Phase 2)Looking for participantsNCT06001658
What this trial is testing

Perioperative Gemcitabine, Cisplatin, and Pembrolizumab in Potentially Resectable Biliary Tract Cancers

Who this might be right for
Billiary Track Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 27
Not applicableStudy completedNCT04476082
What this trial is testing

Nutrition in Gastrointestinal Tumors

Who this might be right for
Pancreatic CancerOesophageal CancerColon Cancer+7 more
University Medicine Greifswald 66
Not applicableLooking for participantsNCT07036848
What this trial is testing

Efficacy and Safety of Surgical Treatment for Type IVa CBD

Who this might be right for
Choledochal Cyst
Beijing Tsinghua Chang Gung Hospital 1,500
Not applicableStudy completedNCT01392274
What this trial is testing

PCLE For the Diagnosis Of Cancer in Unknown Bile Duct Stricture

Who this might be right for
CholangiocarcinomaBile Duct Inflammation
Mauna Kea Technologies 121
Testing effectiveness (Phase 2)WithdrawnNCT03818997
What this trial is testing

Combination of Targeted and Immunotherapy for Advanced Biliary Tract and Esophagogastric Gastric Cancer

Who this might be right for
Esophageal CancerBiliary Tract CancerGastroEsophageal Cancer+1 more
European Organisation for Research and Treatment of Cancer - EORTC
Not applicableUnknownNCT03821025
What this trial is testing

Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction

Who this might be right for
Bile Duct Obstruction, ExtrahepaticCancer of the PancreasCancer of the Bile Duct+1 more
University of Cape Town 150
Not applicableLooking for participantsNCT06715839
What this trial is testing

Target-specific immunoPET Imaging of Digestive System Carcinoma

Who this might be right for
MalignancyDigestive CancerDigestive System Neoplasm+12 more
RenJi Hospital 400
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07269158
What this trial is testing

A Phase IIb Randomized Clinical Trial of Immune Checkpoint Inhibitor-based Maintenance Therapy in Patients With Advanced Biliary Tract Cancer

Who this might be right for
Biliary Tract NeoplasmsAdvanced CancerImmunotherapy
Yonsei University 160
Testing effectiveness (Phase 2)UnknownNCT05509478
What this trial is testing

Lenvatinib Combined With PD-1 Inhibitors as First-line Treatment for Unresectable/Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract Cancer
The First Hospital of Jilin University 46
Not applicableStudy completedNCT04127149
What this trial is testing

Evaluation of Ultra-portable Ultrasound in General Practice

Who this might be right for
PneumoniaPleural EffusionRenal Colic+5 more
Hospices Civils de Lyon 166
Large-scale testing (Phase 3)UnknownNCT01470443
What this trial is testing

Study of GEMOX(Gemcitabine/Oxaliplatin) Versus XELOX(Xeloda/Oxaliplatin) in Advanced Biliary Tract Carcinoma

Who this might be right for
Biliary Tract (Intrahepatic, Extrahepatic Cholangiocarcinoma, Gall Bladder) Cancer
Samsung Medical Center 240
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Early research (Phase 1)Active Not RecruitingNCT02495896
What this trial is testing

Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors

Who this might be right for
Head and Neck Squamous Cell CarcinomaMetastatic Pancreatic AdenocarcinomaNon-Resectable Cholangiocarcinoma+13 more
University of Southern California 61
Not applicableLooking for participantsNCT06060990
What this trial is testing

Determination of Copper and Other Trace Elements in Serum Samples From Patients With Biliary Tract Cancers

Who this might be right for
Trace Element Deficiency
Institute of Oncology Ljubljana 20
Testing effectiveness (Phase 2)Study completedNCT03797326
What this trial is testing

Efficacy and Safety of Pembrolizumab (MK-3475) Plus Lenvatinib (E7080/MK-7902) in Previously Treated Participants With Select Solid Tumors (MK-7902-005/E7080-G000-224/LEAP-005)

Who this might be right for
Advanced Solid TumorsTriple Negative Breast CancerOvarian Cancer+5 more
Merck Sharp & Dohme LLC 611
Early research (Phase 1)WithdrawnNCT02856568
What this trial is testing

Ricolinostat, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Unresectable or Metastatic Cholangiocarcinoma

Who this might be right for
Non-Resectable CholangiocarcinomaRecurrent CholangiocarcinomaStage III Extrahepatic Bile Duct Cancer+10 more
Mayo Clinic
Load More Results